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Abstract Background
 
Recent data highlighted the role of nuclear receptors in the transcriptional
regulation of the limiting enzyme of bile acid synthesis, cholesterol 7
 
α
 
-hydroxylase, in cellular
and animal models. This study was designed to analyze the effects of age on cholesterol
7
 
α
 
-hydroxylase and related nuclear receptor expression in human livers.
 
Design
 
Surgical liver biopsies were obtained in 23 patients requiring operation on the
gastrointestinal tract. mRNA levels of cholesterol 7
 
α
 
-hydroxylase and related nuclear
receptors and co-activators were assayed by quantitative real-time RT-PCR. Serum levels of
7
 
α
 
-hydroxy-4-cholesten-3-one, a marker of bile acid synthesis, were assayed by gas-liquid
chromatography:mass spectrometry.
 
Results
 
Ageing was inversely correlated with serum 7
 
α
 
-hydroxy-4-cholesten-3-one and
with cholesterol 7
 
α
 
-hydroxylase mRNA levels (
 
r 
 
=
 
 –
 
0·44 and 
 
r
 
 
 
=
 
 
 
−
 
0·45 on a semi-log scale,
respectively, 
 
P
 
 < 0·05). Among different nuclear factors, cholesterol 7
 
α
 
-hydroxylase mRNA
best correlated with hepatocyte nuclear factor-4 (
 
r 
 
=
 
 0·55 on a log scale, 
 
P
 
 < 0·05);
hepatocyte nuclear factor-4 levels were also inversely correlated with age (
 
r 
 
=
 
 –
 
0·64 on
a semi-log scale, 
 
P
 
 < 0·05). Age was inversely correlated with serum insulin-like growth
factor-I levels, which were directly correlated with hepatocyte nuclear factor-4 and cholesterol
7
 
α
 
-hydroxylase expression. No suppressive effect of short heterodimer partner expression
on cholesterol 7
 
α
 
-hydroxylase was observed.
 
Conclusions
 
Ageing associates with reduced bile acid synthesis, possibly related to
decreased hepatic expression of hepatocyte nuclear factor-4 and consequently of cholesterol
7
 
α
 
-hydroxylase. Age-related modifications of the growth hormone/insulin-like growth factor
axis might play a role. These findings may help to elucidate the pathophysiology of age-related
modifications of cholesterol metabolism.
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Introduction
 
Hepatic degradation to bile acids is the most relevant
metabolic pathway whereby the organism can dispose of
excess cholesterol [1,2]. Bile acids are known to exert
feedback inhibition on this process and on the activity of
the limiting enzyme of the main biosynthetic pathway,
cholesterol 7
 
α
 
-hydroxylase (CYP7A1) [1–3].
Recent evidence highlighted the role of nuclear receptors
in the transcriptional control of CYP7A1 [4–6] suggesting
a cascade mechanism of control where the interaction of
hydrophobic bile acids with farnesoid X receptor (FXR),
now identified as the bile acid receptor, triggers over-
expression of the co-repressor short heterodimer partner
(SHP) leading in turn to down-regulation of CYP7A1 gene
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transcription [7,8]. This mechanism involves a negative
interaction with the co-activator CYP7A1 promoter binding
factor/liver receptor homologue-1 (CPF/LRH-1). Another
nuclear receptor, hepatocyte nuclear factor 4 (HNF-4),
was shown to exert an important stimulation of CYP7A1
transcription, in part independently of the FXR and SHP-
mediated cascade, via interaction with the transcriptional
complex at the promoter level [6,9].
These mechanisms of regulation have been defined
mainly in cellular models; their role in humans is still largely
unknown. The feedback mechanism is certainly operating
in humans [10,11]; furthermore, manipulations affecting
bile acid synthesis and CYP7A1 activity lead to significant
changes in plasma low-density lipoprotein (LDL) levels,
due to corresponding changes in the expression and func-
tion of the hepatic LDL receptor, as shown with the bile
acid-sequestering agent cholestyramine [11,12]. Therefore,
insight in the regulation of this pathway bears important
implications such as the definition of molecular targets for
the management of hypercholesterolaemia.
The effects of ageing on cholesterol metabolism and on
bile acid synthesis have been characterized in the past.
Epidemiological studies have shown that plasma cholesterol
levels and the prevalence of cholesterol gallstone disease
increase with advancing age [13–15]. Increased biliary
secretion of cholesterol might account for the latter phe-
nomenon [16]; reduction in bile acid synthesis [16,17]
could also play a causal role.
The aims of the present study were to characterize the role
of hepatic nuclear receptors on bile acid synthesis and on
the expression of CYP7A1 in the human liver, and to investigate
the alterations associated with ageing as related with changes
in circulating hormone levels in patients not receiving any
treatment with agents affecting bile acid metabolism.
 
Materials and methods
 
Patients
 
Twenty-three consecutive patients (11 males, 12 females,
age range 18–81 years) referred to the Policlinico Hospital
in Modena for operation were studied. Thirteen of them had
stabilized cholesterol gallstone disease; ten of them required
abdominal operation because of colon cancer, pancreatic
cancer, gastric cancer or liver donation. According to our
protocol, patients with initial gastrointestinal cancer could
be included in the study provided that liver samples were
free from neoplastic disease.
None of the subjects had alterations in liver and gastro-
intestinal function, or major metabolic diseases. None of them
was taking bile acids, cholestyramine or other agents known
to affect cholesterol metabolism. Most of the patients (9
gallstone and 7 control subjects) were already reported
in a preliminary study aimed to investigate the effects of
cholelithiasis on hepatic nuclear receptor expression [18].
The patients gave their informed consent to the protocol of
the study, which was approved by the local Ethical Committee.
During operation, in the morning after an overnight fast,
a liver biopsy (30–150 mg) was taken, immediately frozen
in liquid nitrogen and stored at 
 
−
 
80 
 
°
 
C until analysed.
Histology did not show alterations related to acute or chronic
liver disease; steatosis was either absent or minimal (less
than 20%).
Fasting blood samples were taken for determination
of serum lipids, hormone levels and 7
 
α
 
-hydroxy-4-cholesten-
3-one concentrations.
 
Quantification of hepatic mRNA levels by real-time 
RT-PCR
 
After standard extraction, total RNA was reverse-transcribed
with the Superscript First-Strand Synthesis System
(Invitrogen, Milano, Italy). PCR analysis was performed as
described [18,19], using the IQ Sybr Green Method (Bio-
Rad, Milano, Italy), in order to detect mRNA expression
levels of CYP7A1 and of the main nuclear receptors
involved in its transcriptional regulation, FXR, SHP, CPF/
LRH-1, and HNF-4. 18S rRNA was used as housekeeping
gene.
Results are shown as expression abundance relative to 18 S.
 
Determination of serum 7α
 
-hydroxy-4-cholesten-3-
one, lipid and hormone levels
 
Serum levels of 7
 
α
 
-hydroxy-4-cholesten-3-one were deter-
mined by gas-liquid chromatography: mass spectrometry
(GC-MS) assay as described [18], using 19-hydroxycholesterol
as internal standard. After extraction, purification and deri-
vatization, aliquots of the silylated mixtures were injected
in a Thermofinnigan GC-Q equipment for analysis [18].
Serum concentrations of total cholesterol, high-density
lipoprotein (HDL) cholesterol, LDL cholesterol and
triglycerides were determined by enzymatic-colorimetric
technique (Boehringer, Mannheim, Germany) on an auto-
mated equipment (Modular, Roche, Mannheim, Germany);
apo AI and apo B were analysed by standard immunochemical-
nephelometric analysis on a BNII instrument (Dade
Behring, Eschborn, Germany).
Basal serum levels of insulin, C-peptide, thyrotropin (TSH),
free triiodothyronine (F-T
 
3
 
) and free thyroxine (F-T
 
4
 
) were
determined by chemiluminescence on an Advia Centaur
equipment (Bayer Italia, Milano, Italy); growth hormone
(GH) and insulin-like growth factor-I (IGF-I) were determined
by chemiluminescence on a Liaison equipment (DiaSorin,
Saluggia, Italy).
 
Statistical analysis
 
Linear correlation analysis and, when appropriate, multiple
stepwise regression analysis were performed by the least
square method. Analysis with relative mRNA tissue contents
was conducted after log transformation in order to better
approximate normal distribution.
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Significance was accepted at the 
 
P
 
 < 0·05 level. Statistical
analysis was performed with the aid of SPSS statistical
software (version 13·0 for Windows) on a PC workstation.
 
Results
 
As illustrated in Fig. 1, a significant correlation (
 
r =
 
 0·50,
 
P
 
 < 0·05) is present between hepatic expression of CYP7A1
and serum concentrations of 7
 
α
 
-hydroxy-4-cholesten-3-
one, a precursor of primary bile acids recognized as a
marker of bile acid synthesis rate and of CYP7A1 activity
[20]. These data confirm that circulating levels of 7
 
α
 
-
hydroxy-4-cholesten-3-one mirror to some extent hepatic
expression, and presumably activity, of CYP7A1 even in the
absence of treatment with agents affecting bile acid and lipid
metabolism.
Figure 2 shows the correlation between tissue expression
of CYP7A1 and the nuclear receptors/co-regulators inves-
tigated, expressed on a log scale. Simple regression analysis
showed a significant direct correlation with tissue expression
of HNF-4 and CPF/LRH-1, and a non-significant correla-
tion trend with SHP. A similar non-significant trend was
also observed with FXR (
 
r =
 
 0·38, 
 
P
 
 = n.s., data not illus-
trated). When performing stepwise linear regression analysis
with CYP7A1 expression as the dependent variable, the
highest degree of correlation was detected with HNF-4
expression (
 
r =
 
 0·55, 
 
P <
 
 0·05), all other genes bringing
non-significant contribution. Tissue expression of HNF-4
was also highly correlated with that of CPF/LRH-1
(
 
r =
 
 0·65, 
 
P <
 
 0·05); furthermore, HNF-4 mRNA levels
were significantly correlated with serum concentrations of
7
 
α
 
-hydroxy-4-cholesten-3-one (
 
r =
 
 0·47, 
 
P
 
 < 0·05) (data
not illustrated).
No difference in tissue expression of any of the genes
investigated was detected in subjects with cholesterol
Figure 1 Correlation between hepatic gene expression of CYP7A1 
and serum levels of 7α-hydroxy-4-cholesten-3-one as a marker of 
bile acid synthesis rate and of CYP7A1 activity in the population 
investigated (n = 21). The relative mRNA abundance of CYP7A1 
was assayed by quantitative real-time RT-PCR and expressed 
as relative to 18 S as housekeeping gene. Serum concentrations of 
7α-hydroxy-4-cholesten-3-one were assayed by GC-MS.
Linear regression analysis was performed by the least square 
method after log transformation of CYP7A1 mRNA levels. 
r = 0·50, P < 0·05.
Figure 2 Correlation between tissue gene expression levels of 
CYP7A1 (as the dependent variable) and, from top to bottom, 
HNF-4, CPF/LRH-1 and SHP in the patients investigated 
(n = 23). The relative mRNA abundance of the individual genes 
was assayed by quantitative real-time RT-PCR and expressed as 
relative to 18 S as housekeeping gene. Linear regression analysis 
was performed by the least square method after log transformation.
HNF-4 vs. CYP7A1: r = 0·55, P < 0·05.CPF/LRH-1 vs. CYP7A1: 
r = 0. 48, P < 0·05. SHP vs. CYP7A1: r = 0·38, P = n.s.
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gallstone disease versus those without gallstones, in
agreement with a preliminary report of this group [18] (data
not shown).
As shown in Fig. 3, a significant inverse correlation
was detected between age and tissue CYP7A1 expression.
A significant correlation was also observed between age and
serum 7
 
α
 
-hydroxy-4-cholesten-3-one (
 
r 
 
=
 
 –
 
0·44, 
 
P
 
 < 0·05,
data not illustrated). In particular, a close inverse correlation
was detected between age and hepatic expression of HNF-4
(
 
r 
 
=
 
 –
 
0·64, 
 
P
 
 < 0·05). No correlation was present with the
other nuclear receptors investigated (data not shown).
Table 1 shows the lipid parameters and the hormones
analysed in the study.
A significant inverse correlation was detected between age
and plasma F-T
 
3
 
 (
 
r 
 
=
 
 –
 
0·57, 
 
P
 
 
 
<
 
 0·05, data not illustrated)
and between age and IGF-I (Fig. 4). Circulating levels of
other hormones investigated (insulin, C-peptide, TSH,
F-T
 
4
 
, GH) were not significantly correlated with age (data
not shown).
Whereas serum F-T
 
3
 
 did not show a significant correlation
with any of the parameters investigated (data not shown),
serum concentrations of IGF-I were directly correlated with
serum 7
 
α
 
-hydroxy-4-cholesten-3-one, with tissue expression
of CYP7A1 and of HNF-4 as illustrated in Fig. 5.
No correlation was observed between age and any of the
investigated parameters of lipid profile (serum total choles-
terol, HDL cholesterol, LDL cholesterol, triglycerides, apo
AI, apo B) in the present patient group; likewise, no corre-
lation was present between any of these parameters and gene
expression levels of CYP7A1 and of the other nuclear
receptors analysed (data not shown).
 
Discussion
 
A body of experimental data has recently brought new
insights into the molecular mechanisms of regulation of bile
acid synthesis [5,6,9]; nonetheless direct evidence in
humans, in particular concerning the regulation of CYP7A1
expression, is scarce.
Previous findings by Rudling 
 
et al
 
. [21] have shown spe-
cular changes in hepatic mRNA abundance of CYP7A1 after
treatment with cholestyramine and chenodeoxycholic acid;
such changes were also correlated with tissue abundance of
LDL receptor.
A recent report by Abrahamsson 
 
et al
 
. suggested that
changes in CYP7A1 mRNA after resin treatment might be
mediated by alterations in hepatic expression of HNF-4
[22]. Our evidence, obtained in a population of untreated
subjects, is in agreement with these data.
The present results show a strict correlation between
hepatic CYP7A1 abundance and HNF-4 mRNA levels. At
multiple regression analysis, HNF-4 expression was the
Figure 3 Correlation between age and tissue expression of 
CYP7A1 (upper panel, n = 23) and tissue expression of HNF-4 
(lower panel, n = 23). The relative mRNA abundance of CYP7A1 
and HNF-4 was assayed by quantitative real-time RT-PCR and 
expressed as relative to 18 S as housekeeping gene. Linear 
regression analysis was performed by the least square method after 
log transformation of CYP7A1 and HNF-4 mRNA levels. Age vs. 
CYP7A1: r = −0·45, P < 0·05. Age vs. HNF-4: r = −0·64, 
P < 0·05.
Figure 4 Correlation between age and serum levels of IGF-I in 
the population investigated (n = 23). Serum hormone levels were 
analysed by chemiluminescence analysis. Linear regression analysis 
was performed by the least square method. Age vs. IGF-I: 
r = −0·43, P < 0·05.
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Figure 5 Correlation between serum levels of IGF-I and serum 
concentrations of 7α-hydroxy-4-cholesten-3-one (upper panel, 
n = 21), tissue expression of CYP7A1 (middle panel, n = 23) and 
tissue expression of HNF-4 (lower panel, n = 23). Serum IGF-I 
levels were analysed by chemiluminescence analysis. Serum 
concentrations of 7α-hydroxy-4-cholesten-3-one were assayed by 
GC-MS. The relative mRNA abundance of CYP7A1 and HNF-4 
was assayed by quantitative real-time RT-PCR and expressed as 
relative to 18 S as housekeeping gene. Linear regression analysis 
was performed by the least square method after log transformation 
of CYP7A1 and HNF-4 mRNA levels. IGF-I vs. 7α-hydroxy-4-
cholesten-3-one: r = 0·44, P < 0·05.IGF-I vs. CYP7A1: r = 0. 43, 
P < 0·05. IGF-I vs. HNF-4: r = 0·49, P < 0·05.
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closest predictor of CYP7A1 expression, all other genes
bringing non-significant contribution to the regression
profile. Of course, the mere presence of a correlation does
not imply a cause and effect relationship between the
parameters investigated, but the present data are highly
suggestive for a modulating effect of HNF-4 on bile acid
synthesis. This view is further supported by the data on
circulating 7α-hydroxy-4-cholesten-3-one, whose levels
correlate with tissue expression of HNF-4.
Serum levels of this precursor of bile acid synthesis
correlate with tissue expression of CYP7A1 (see Fig. 1).
Whereas the correspondence between serum 7α-hydroxy-
4-cholesten-3-one concentrations and hepatic CYP7A1
activity is well characterized [20], as far as we know this is
the first report which directly addresses the relationship with
hepatic CYP7A1 expression.
Evidence in patients with cerebrotendineous xanthoma-
tosis is also indirectly consistent with a role of HNF-4 as a
transcriptional activator of CYP7A1 [23]. Finally, a body
of evidence has supported a relevant role of HNF-4 as an
activator of CYP7A1 transcription in nonhuman models
[24–26].
Experiments are currently underway to determine hepatic
protein levels of CYP7A1 and HNF-4 as related to gene
expression profile in untreated and treated conditions.
Hepatic abundance of CPF/LRH-1 also correlates with
CYP7A1 and with HNF-4 expression. With the limitations
previously mentioned, our findings are consistent with a
reciprocal interaction of these two transcriptional activators,
suggested by previous findings [27].
Surprisingly, no negative correlation between SHP and
CYP7A1 was detected; a positive trend was instead dis-
closed. This is against the leading hypothesis of a regulatory
cascade with a crucial role of SHP in down-regulating
CYP7A1 transcription [7,8].
It is likely that in man, at least in basal conditions, SHP-
mediated suppression is not the predominant mechanism
of regulation of bile acid synthesis. We cannot rule out that
in different clinical settings changes in SHP expression may
take place and bring a more substantial regulatory contri-
bution; nonetheless it is interesting to recall that even in the
previously mentioned paper by Abrahamsson et al. [22] no
changes in SHP expression were shown with either cheno-
deoxycholic acid or cholestyramine treatment. Obviously,
our findings do not rule out the possibility of a regulatory
role of SHP on CYP7A1 transcription, independently of
measurable changes in its expression levels, in the presence
of other coactivators. At any rate, these findings underline
the difficulty to extrapolate data obtained in cultured cells
and in experimental animals to the complexity of human
physiology.
The role of SHP-independent mechanisms in the regu-
lation of bile acid synthesis and of CYP7A1 transcription
has been underlined [28,29], highlighting the role of path-
ways involving cytokine expression and intracellular kinase
pathways [30,31] and showing that bile acids impair the
transcriptional machinery by determining the dissociation
of transcriptional coactivators from the CYP7A1 promoter
[19].
We obviously cannot rule out a relevant role for other
nuclear receptors/co-activators or enzymes that were not
investigated in the present study; preliminary data from this
laboratory ([18] and Bertolotti et al. unpublished observa-
tions) failed to show, at any rate, any significant correlation
between hepatic mRNA content of CYP7A1 and tissue
expression of peroxysome proliferator-activated receptor
(PPAR)-γ coactivator-1 (PGC-1), a co-activator whose role
in the molecular regulation of bile acid synthesis and
CYP7A1 transcription has been underlined [9], nor with
hepatic expression of phosphoenolpyruvate carboxykinase
(PEPCK), an enzyme of gluconeogenesis whose regulation
was shown to mirror that of CYP7A1 [19].
The data presented indicate that ageing inversely cor-
relates with bile acid synthesis and hepatic CYP7A1 expres-
sion. Even if the literature in this regard is scarce, the present
findings are consistent with previous evidence obtained
in humans in vivo by this group [17] and by others [16].
Such reduced rate of bile acid synthesis may play a
relevant role in a number of alterations of cholesterol
metabolism, among which increased biliary cholesterol
saturation and cholesterol gallstone disease prevalence,
observed with advancing age.
We were not able to observe any changes in lipid and
lipoprotein profile, either related to age or to hepatic gene
expression of CYP7A1 and of the investigated nuclear
receptors. We need to consider that serum cholesterol and
triglyceride levels are influenced by many interacting factors
and subtle spontaneous changes in bile acid synthesis and
CYP7A1 expression may have failed to bear a significant
impact in a relatively small patient population.
The causes of age-related reduction of bile acid synthesis
and CYP7A1 expression remain to a large extent elusive;
a reduction in whole body bile acid synthesis might theo-
retically be accounted for by a reduction in functioning liver
mass, as suggested by studies on quantitative liver function
[32]. The described decrease in CYP7A1 expression indeed
points toward more subtle mechanisms of regulation, which
might be related to the observed changes in the hormonal
pattern.
Our data on the inverse correlation between ageing and
IGF-I are consistent with previous epidemiological evidence
[33] and suggest a causal relationship between IGF-I levels
and bile acid synthesis/CYP7A1 expression, which might
involve HNF-4 as a critical regulator. In animal model experi-
mental treatment with GH was shown to induce hepatic
expression of HNF-4 and other liver-enriched transcription
factors as well [34–36]; on the other hand, members of the
hepatocyte nuclear factor (HNF) family, a group of liver-
enriched transcription factors with relevant functions in
liver differentiation and function [37] are capable of
modulating the expression of IGF-I in isolated cell model
[38,39]. It cannot therefore be excluded that hormones
of the GH/IGF axis and members of the HNF family can
modulate each other in a feed-forward loop.
Whatever the intimate molecular pathways of regulation,
quite a few pieces of evidence support the view that GH
may exert a stimulatory action on bile acid synthesis. Data
in hypophysectomized rats and mice have shown reduced
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serum levels of 7α-hydroxy-4-cholesten-3-one and CYP7A1
activity, which could partly be reversed by GH treatment
[40,41]. Data in humans are once again conflicting; previous
evidence using faecal sterol analysis showed a stimulatory
effect of GH treatment on bile acid production in GH-
deficient subjects [42], whereas more recent evidence failed
to show an increase in serum 7α-hydroxy-4-cholesten-3-one
in comparable conditions [43]. We have no obvious
explanation for these discrepancies; we might speculate that
physiological age-related changes in IGF-I levels exert dif-
ferent metabolic effects compared with those induced by
GH treatment. Furthermore, previous reports have suggested
that the metabolic effects of GH and those of IGF-I
may be relatively distinct, and independent on each other
[44,45].
In conclusion, the present findings support a regulatory
role for HNF-4, and possibly for CPF/LRH-1, on bile acid
synthesis and hepatic CYP7A1 expression with no evidence
for a suppressive role of SHP. The reduction of bile acid syn-
thesis and CYP7A1 expression related with ageing is probably
mediated by corresponding alterations in the GH/IGF axis
and in HNF-4 expression. These data might help to clarify
the pathogenesis of some of the changes in cholesterol
metabolism observed with advancing age and, hopefully, to
identify potential molecular targets for novel pharmacological
approaches aimed to prevent the onset and complications
of cholesterol accumulation conditions.
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